Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New surgical technique may help men regain bladder control faster after prostate cancer surgery

NCT ID NCT07305142

Disease control Sponsor: The First Affiliated Hospital of Zhengzhou University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two robot-assisted surgical techniques for removing the prostate in men with prostate cancer. One method uses a combined posterior-anterior-lateral (PAL) approach, while the other uses a traditional posterior approach. The goal was to see which technique leads to better urinary continence and recovery. Sixty participants were randomly assigned to one of the two procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robot-assisted surgical procedure (PAL combined approach vs posterior approach)
What this could lead to
If successful, the PAL approach could improve early urinary continence after prostate cancer surgery.
What could go wrong
This is a small, completed study with only 60 participants, so results may not apply to all patients. Surgical risks like bleeding or complications remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

May 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 80 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Prostate biopsy confirms prostate cancer; * Clinical T stage \<=T3a stage; * Fully understand clinical trial protocols and sign informed consent; Exclusion Criteria: * Urinary incontinence before surgery; * Previous endoscopic prostate surgery; * There are serious underlying diseases that cannot tolerate surgery or have a survival of less than 5 years; * Metastatic disease is present or lymph node involvement is suspected at diagnosis; * Patients judged by the investigator to be unsuitable for participation in this clinical trial;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prostate are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign urinary system neoplasm malignant urinary system neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate Robot assisted laparoscopic radical prostatectomy Urologic cancer

Contacts and locations

Locations

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.